Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23446

1.

Design, synthesis and antimicrobial evaluation of propylene-tethered ciprofloxacin-isatin hybrids.

Wang R, Yin X, Zhang Y, Yan W.

Eur J Med Chem. 2018 Jul 16;156:580-586. doi: 10.1016/j.ejmech.2018.07.025. [Epub ahead of print]

PMID:
30025351
2.

A multimodal rehabilitation program for patients with ICU acquired weakness improves ventilator weaning and discharge home.

Verceles AC, Wells CL, Sorkin JD, Terrin ML, Beans J, Jenkins T, Goldberg AP.

J Crit Care. 2018 Jul 11;47:204-210. doi: 10.1016/j.jcrc.2018.07.006. [Epub ahead of print]

PMID:
30025227
3.

Therapeutic effects of recombinant human interleukin 2 as adjunctive immunotherapy against tuberculosis: A systematic review and meta-analysis.

Zhang R, Xi X, Wang C, Pan Y, Ge C, Zhang L, Zhang S, Liu H.

PLoS One. 2018 Jul 19;13(7):e0201025. doi: 10.1371/journal.pone.0201025. eCollection 2018.

PMID:
30024982
4.

Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.

Meyvisch P, Kambili C, Andries K, Lounis N, Theeuwes M, Dannemann B, Vandebosch A, Van der Elst W, Molenberghs G, Alonso A.

PLoS One. 2018 Jul 19;13(7):e0200539. doi: 10.1371/journal.pone.0200539. eCollection 2018.

PMID:
30024924
5.

Widening the Therapeutic Perspectives of Clofazimine by its Loading in Sulfobutylether β-Cyclodextrin Nanocarriers: Nanomolar IC50 Values against MDR S. epidermidis.

Wankar J, Bonvicini F, Benkovics G, Marassi V, Malanga M, Fenyvesi E, Gentilomi GA, Reschiglian P, Roda B, Manet I.

Mol Pharm. 2018 Jul 19. doi: 10.1021/acs.molpharmaceut.8b00321. [Epub ahead of print]

PMID:
30024758
6.

Porphyrin-Gold Nanomaterial for Efficient Drug Delivery to Cancerous Cells.

Bera K, Maiti S, Maity M, Mandal C, Maiti NC.

ACS Omega. 2018 Apr 30;3(4):4602-4619. doi: 10.1021/acsomega.8b00419. Epub 2018 Apr 26.

PMID:
30023896
7.

The complete genome sequence of Rhodobaca barguzinensis alga05 (DSM 19920) documents its adaptation for life in soda lakes.

Kopejtka K, Tomasch J, Bunk B, Spröer C, Wagner-Döbler I, Koblížek M.

Extremophiles. 2018 Jul 18. doi: 10.1007/s00792-018-1041-8. [Epub ahead of print]

PMID:
30022245
8.

Rifampin- or Capreomycin-Induced Remodeling of the Mycobacterium smegmatis Mycolic Acid Layer Is Mitigated in Synergistic Combinations with Cationic Antimicrobial Peptides.

Man DK, Kanno T, Manzo G, Robertson BD, Lam JKW, Mason AJ.

mSphere. 2018 Jul 18;3(4). pii: e00218-18. doi: 10.1128/mSphere.00218-18.

PMID:
30021876
9.

The effects of DMARDs on the expression and function of P-gp, MRPs, BCRP in the treatment of autoimmune diseases.

Wu YJ, Wang C, Wei W.

Biomed Pharmacother. 2018 Sep;105:870-878. doi: 10.1016/j.biopha.2018.06.015. Epub 2018 Jun 18. Review.

PMID:
30021380
10.

Pneumonia, Bacterial.

Sattar SBA, Haseer Koya H.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Jul 8.

11.

In vitro effects of ciprofloxacin, levofloxacin and moxifloxacin on Mycobacterium tuberculosis isolates.

Yılmaz FF, Eraç B, Ermertcan Ş, Çavuşoğlu C, Biçmen C, Aktoğu Özkan S, Hoşgör Limoncu M.

Tuberk Toraks. 2018 Mar;66(1):32-36. doi: 10.5578/tt.58677.

PMID:
30020039
12.

Drug resistance pattern in Mycobacterium tuberculosis to the first line drugs of pulmonary tuberculosis patients at Hazara Region, Pakistan.

Jan F, Wali S, Sadia S, Akbar MT, Akbar HS, Ahmad W, Ahmad M, Khalid A.

Tuberk Toraks. 2018 Mar;66(1):26-31. doi: 10.5578/tt.60781.

PMID:
30020038
13.

Occurrence of adverse events in patient receiving community-based therapy for multidrug-resistant tuberculosis in Pakistan.

Javaid A, Khan MA, Jan F, Rauf M, Khan MA, Basit A, Mehreen S.

Tuberk Toraks. 2018 Mar;66(1):16-25. doi: 10.5578/tt.64054.

PMID:
30020037
14.

Three-Dimensional Characterization of Trabecular Bone Mineral Density of the Distal Radius Utilizing Quantitative Computed Tomography.

Pidgeon TS, DaSilva KA, Crisco JJ, Johnson EC, Chambers AB, DaSilva MF.

Hand (N Y). 2018 Jul 1:1558944718789407. doi: 10.1177/1558944718789407. [Epub ahead of print]

PMID:
30019965
15.

New ABCC2 rs3740066 and rs2273697 Polymorphisms Identified in a Healthy Colombian Cohort.

Bustos-Cruz RH, Martínez LR, García JC, Barreto GE, Suárez F.

Pharmaceutics. 2018 Jul 17;10(3). pii: E93. doi: 10.3390/pharmaceutics10030093.

16.

A Xenobiotic Detoxification Pathway through Transcriptional Regulation in Filamentous Fungi.

Sang H, Hulvey JP, Green R, Xu H, Im J, Chang T, Jung G.

MBio. 2018 Jul 17;9(4). pii: e00457-18. doi: 10.1128/mBio.00457-18.

17.

Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.

Kerstenetzky L, Heimerl KM, Hartkopf KJ, Hager DR.

J Am Pharm Assoc (2003). 2018 Jul 15. pii: S1544-3191(18)30227-9. doi: 10.1016/j.japh.2018.05.007. [Epub ahead of print]

PMID:
30017369
18.

[Hospital-acquired pneumonia in the light of current recommendations - is there a space for improving patient care?]

Doubravská L, Uvízl R, Gabrhelík T, Klementová O, Kolář M.

Klin Mikrobiol Infekc Lek. 2018 Mar;24(1):4-9. Czech.

PMID:
30016532
19.

Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.

Laudy AE.

Pol J Microbiol. 2018 Jun 30;67(2):129-135. doi: 10.21307/pjm-2018-017.

PMID:
30015451
20.

Pre-intensive care unit intubation and subsequent delayed intensive care unit admission is independently associated with increased occurrence of ventilator-associated pneumonia.

Tsakiridou E, Mega AM, Zakynthinos E, Melissopoulou T, Stamos G, Argyriou K, Pangrati S, Deliolanis I, Floros I.

Clin Respir J. 2018 Jul 17. doi: 10.1111/crj.12944. [Epub ahead of print]

PMID:
30015372

Supplemental Content

Loading ...
Support Center